FDA recalls potentially dangerous drugs about once per month, but the agency could better inform physicians and patients about its decisions, according to a study published in the Archives of Internal Medicine. Between 2004 and 2011, FDA failed to utilize two of its electronic alert systems to publicize one-fifth of Class 1 drug recalls, which FDA has designated for medications that could potentially cause "serious adverse health consequences or death."